Cooper Companies Exceeds Expectations in Q3 2026, Emphasizes Fertility Growth and Strategic Review Completion
The Cooper Companies has wrapped up a successful third quarter of 2026, boasting earnings that surpassed expectations. According to Al White, President and Chief Executive Officer, the company's results were driven by strong fertility growth at CooperSurgical, as well as the favorable completion of a significant tax matter.
At CooperVision, however, the company opted to proactively reduce U.S. channel inventory, which had a notable impact on their quarterly results. Despite this, the underlying demand in the United States remained healthy, with consumption increasing at a mid-single-digit rate. This sets the stage for a stronger foundation heading into fiscal 2027.
The strategic review process, announced separately earlier today, has come to a conclusion. After conducting a comprehensive evaluation of alternatives, including a potential sale of CooperSurgical, the board unanimously decided against pursuing a transaction at this time. According to Al White, this decision was influenced by temporary factors such as the impact of fertility litigation settlement and developments related to a competitive entrant in the non-hormonal IUD market.
The company believes these factors resulted in offers that did not accurately reflect CooperSurgical's intrinsic value and long-term potential. Nevertheless, The Cooper Companies remains committed to enhancing shareholder value through profitable organic growth and disciplined capital allocation, including share repurchases.
CooperVision reported revenue of $717 million for the quarter, a figure essentially flat year-over-year. While EMEA and Asia-Pac regions performed in line with expectations, the Americas results were impacted by CooperVision's U.S. channel inventory reductions. The company sees opportunities to bolster growth through improved execution of contract wins and product launches.
Key initiatives aimed at achieving this include expanded sales coverage, increased customer marketing programs, and enhanced commercial execution capabilities powered by AI-driven targeting and analytics tools. These efforts are already showing traction in Asia-Pac and the U.S., where a new commercial leadership team is fully in place.
The Cooper Companies' commitment to strategic alternatives remains unchanged, with ongoing evaluation of opportunities to maximize long-term shareholder value.
